Yubo International Biotech Ltd SEC filings YBGJ

Yubo International Biotech Ltd has 284 filings in SEC EDGAR's recent list, going back to May 29, 1996. Its latest annual report, Form ARS, was filed on Jun 12, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Jan 16, 2026 (auditor change). The company's fiscal year ends on December 31.

Yubo International Biotech Ltd SEC filings
Form Description Filed Period
DEF 14C Information statement Jun 12, 2026 Jun 10, 2026
DEF 14C Information statement Apr 14, 2025 Apr 8, 2025
PRE 14C Filing Apr 2, 2025 Apr 1, 2025
DEF 14C Information statement Mar 24, 2021 Mar 24, 2021
PRE 14C Filing Mar 12, 2021 Mar 12, 2021
DEF 14C Information statement Nov 12, 2020 Nov 12, 2020
PRE 14C Filing Nov 2, 2020 Nov 2, 2020
DEF 14C Information statement Oct 25, 2006 Nov 17, 2006
PRE 14C Preliminary information statement Oct 10, 2006 Nov 17, 2006
DEF 14A Proxy statement Aug 8, 2001 Aug 21, 2001
PRE 14A Preliminary proxy statement Jul 20, 2001 Aug 21, 2001
DEF 14A Proxy statement Sep 28, 2000 Sep 28, 2000
PRE 14A Preliminary proxy statement Aug 25, 2000 Sep 28, 2000
DEF 14A Proxy statement Jun 28, 1996 Jul 24, 1996

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
YBGJ (OTC)
Fiscal year ends
December 31
Incorporated in
NY
Headquarters
Beijing, China
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
895464
Former names
MAGNA LAB INC (until Dec 4, 2020)

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.